Guangzhou Baiyunshan Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 27,057

Employees

  • Stock Symbol
  • 600332

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $2.88
  • (As of Friday Closing)

Guangzhou Baiyunshan General Information

Description

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.

Contact Information

Formerly Known As
Guangzhou Pharmaceutical Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 45 ShaMian North Street, Liwan District
  • Liwan District
  • Guangzhou, Guangdong 510130
  • China
+86 020
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Corporate Office
  • 45 ShaMian North Street, Liwan District
  • Liwan District
  • Guangzhou, Guangdong 510130
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangzhou Baiyunshan Stock Performance

As of 20-Nov-2026, Guangzhou Baiyunshan’s stock price is $2.88. Its current market cap is $4.4B with 1.63B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.88 $2.91 $2.84 - $3.75 $4.4B 1.63B 7.42M $0.19

Guangzhou Baiyunshan Financials Summary

As of 30-Sep-2026, Guangzhou Baiyunshan has a trailing 12-month revenue of $11.3B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 5,792,369 6,312,867 5,801,887 5,433,309
Revenue 11,334,637 10,798,589 10,451,291 10,673,736
EBITDA 435,601 673,642 626,673 848,041
Net Income 314,044 414,821 395,166 573,251
Total Assets 13,010,556 12,078,714 11,189,383 11,086,375
Total Debt 2,841,971 2,188,927 1,903,652 1,685,915
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangzhou Baiyunshan Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guangzhou Baiyunshan‘s full profile, request access.

Request a free trial

Guangzhou Baiyunshan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangzhou Baiyunshan Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Guangzhou Baiyunshan‘s full profile, request access.

Request a free trial

Guangzhou Baiyunshan Investments & Acquisitions (8)

Guangzhou Baiyunshan’s most recent deal was a Merger/Acquisition with Pharmaceutical Industry for . The deal was made on 03-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pharmaceutical Industry 03-Mar-2026 Merger/Acquisition Distributors (Healthcare)
Zhejiang Medicine 03-Mar-2026 Merger/Acquisition Pharmaceuticals
Hangrun Tech 23-May-2024 Later Stage VC Aerospace and Defense
Guangzhou Pharmaceuticals 15-Dec-2022 Secondary Transaction - Private Distributors (Healthcare)
Wanglaoji 01-Sep-2018 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Guangzhou Baiyunshan ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

18.07 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view Guangzhou Baiyunshan’s complete esg history, request access »

Guangzhou Baiyunshan Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Pharmaceutical Industry Hangzhou, China 1999
Zhejiang Medicine Shaoxing, China 1997
Wanglaoji Guangzhou, China 1992

Guangzhou Baiyunshan FAQs

  • When was Guangzhou Baiyunshan founded?

    Guangzhou Baiyunshan was founded in 1997.

  • Where is Guangzhou Baiyunshan headquartered?

    Guangzhou Baiyunshan is headquartered in Guangzhou, China.

  • What is the size of Guangzhou Baiyunshan?

    Guangzhou Baiyunshan has 27,057 total employees.

  • What industry is Guangzhou Baiyunshan in?

    Guangzhou Baiyunshan’s primary industry is Pharmaceuticals.

  • Is Guangzhou Baiyunshan a private or public company?

    Guangzhou Baiyunshan is a Public company.

  • What is Guangzhou Baiyunshan’s stock symbol?

    The ticker symbol for Guangzhou Baiyunshan is 600332.

  • What is the current stock price of Guangzhou Baiyunshan?

    As of 20-Nov-2026 the stock price of Guangzhou Baiyunshan is $2.88.

  • What is the current market cap of Guangzhou Baiyunshan?

    The current market capitalization of Guangzhou Baiyunshan is $4.4B.

  • What is Guangzhou Baiyunshan’s current revenue?

    The trailing twelve month revenue for Guangzhou Baiyunshan is $11.3B.

  • What is Guangzhou Baiyunshan’s annual earnings per share (EPS)?

    Guangzhou Baiyunshan’s EPS for 12 months was $0.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process